Scientists at St. Jude Children's Research Hospital have shown that specific brain cells respond differently to H3.3 K27M, a mutation in the histone H3.3 protein that drives many cases of diffuse midline glioma (DMG), depending on the cells' location in the developing brain. These findings help explain why DMG, a pediatric brain cancer commonly associated with this mutation, typically arises in the brainstem and other midline regions. The study was published today in Nature Communications.
Discover Recifes.net
This story is part of Recifes international coverage. Explore the platform and follow us — new English social channels come next.
